1023 related articles for article (PubMed ID: 1751545)
21. Stimulation of B-Raf increases c-Jun and c-Fos expression and upregulates AP-1-regulated gene transcription in insulinoma cells.
Langfermann DS; Rössler OG; Thiel G
Mol Cell Endocrinol; 2018 Sep; 472():126-139. PubMed ID: 29225069
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation.
Choi HS; Choi BY; Cho YY; Mizuno H; Kang BS; Bode AM; Dong Z
Cancer Res; 2005 Jul; 65(13):5818-27. PubMed ID: 15994958
[TBL] [Abstract][Full Text] [Related]
23. Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun.
Papavassiliou AG; Treier M; Chavrier C; Bohmann D
Science; 1992 Dec; 258(5090):1941-4. PubMed ID: 1470918
[TBL] [Abstract][Full Text] [Related]
24. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells.
Mollinedo F; Gajate C; Modolell M
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):325-9. PubMed ID: 8092982
[TBL] [Abstract][Full Text] [Related]
25. Antisense rescue defines specialized and generalized functional domains for c-Fos protein.
Holt JT
Mol Cell Biol; 1993 Jun; 13(6):3821-30. PubMed ID: 8497282
[TBL] [Abstract][Full Text] [Related]
26. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
Kerppola TK; Curran T
Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
[TBL] [Abstract][Full Text] [Related]
27. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
28. Leukotriene B4 stimulates c-fos and c-jun gene transcription and AP-1 binding activity in human monocytes.
Stanková J; Rola-Pleszczynski M
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):625-9. PubMed ID: 1313226
[TBL] [Abstract][Full Text] [Related]
29. Signal transduction: the nuclear target.
Kerr LD; Inoue J; Verma IM
Curr Opin Cell Biol; 1992 Jun; 4(3):496-501. PubMed ID: 1497922
[TBL] [Abstract][Full Text] [Related]
30. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
33. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
34. c-fos and c-jun expression in the liver of silver carp and the effect of microcystins.
Li Y; Ma J; Fang Q; Li X
J Biochem Mol Toxicol; 2014 Apr; 28(4):157-66. PubMed ID: 24574083
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion.
Gillardon F; Eschenfelder C; Uhlmann E; Hartschuh W; Zimmermann M
Oncogene; 1994 Nov; 9(11):3219-25. PubMed ID: 7936645
[TBL] [Abstract][Full Text] [Related]
36. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
Li H; Xie P; Li G; Hao L; Xiong Q
Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
[TBL] [Abstract][Full Text] [Related]
37. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
Owen TA; Bortell R; Yocum SA; Smock SL; Zhang M; Abate C; Shalhoub V; Aronin N; Wright KL; van Wijnen AJ
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9990-4. PubMed ID: 2124710
[TBL] [Abstract][Full Text] [Related]
38. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
[TBL] [Abstract][Full Text] [Related]
39. The temporal and cellular expression of c-fos and c-jun in mechanically stimulated rabbit latissimus dorsi muscle.
Osbaldeston NJ; Lee DM; Cox VM; Hesketh JE; Morrison JF; Blair GE; Goldspink DF
Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):465-71. PubMed ID: 7772028
[TBL] [Abstract][Full Text] [Related]
40. Cellular and molecular mechanisms that mediate insulin-dependent rat granulosa cell mitosis.
Peluso JJ; Luciano AM; Pappalardo A; White BA
Biol Reprod; 1995 Jan; 52(1):124-30. PubMed ID: 7711171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
